EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

EFFECT OF HEMODIALYSIS ON CONCENTRATION OF TOTAL PROSTATE SPECIFIC ANTIGEN AMONG PATIENTS WITH CHRONIC RENAL FAILURE ATTENDING BRACK GENERAL HOSPITAL AL-SHATI, LIBYA

Ali, F. Hawad, Abdullah Shebah*, Eljelani Salim, A.A. Elwafa, Abdulbasit Naiel, Maryam M. Bisher, Nabiha Aljoaad, Albashir M. A. Yhmed, Mohamed Farag Elbreki and Hamzah Saad

ABSTRACT

Hemodialysis is the most common method used for renal replacement therapy for patients with kidney disease. Tumor markers (TMs) are widely used for the follow-up of progression and response to treatment of certain neoplastic diseases, but their specificity in hemodialysis patients is controversial. Prostate-specific antigen (PSA) has been shown to be a useful marker in the early detection of prostate cancer. Objective: this study were aimed to determine the total prostate–specific antigen (t–PSA) levels in hemodialysis patients in comparison to normal subjects, as well as the influence of the dialysis duration on its levels. Materials and Methods: This study was conducted on 44 persones, from which 22 hemodialysis patients suffering from Renal Failure and 22 persones seemingly healthy people, they were used as control samples. Results: t-PSA in hemodialysis patients had higher t-PSA levels compared with the healthy subjects (0.8 ±0.80 vs.0. 6 ±0.33 ng/ml, p ˃ 0.05), although this difference was not statistically significant. Concentration of t-PSA was varied among patient groups according to their dialysis periods, hence t-PSA levels were decreased as dialysis period increased. However, this variation was not statistically significant (p ˃ 0.05). Conclusion: In this present study, the increased levels of t-PSA concentration were recorded among both hemodialysis patients and Dialysis patients who have fewer years of dialysis, however, statistical analysis has shown no significance. as the P-value was (p ˃ 0.05).

Keywords: Prostate-specific antigen, Renal failure, Hemodialysis, TMs, Dialysis periods.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 March 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: MARCH ISSUE PUBLISHED

    MARCH 2024 issue has been successfully launched on MARCH 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia